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Abstract
Background: The ankle region is frequently involved in juvenile idiopathic arthritis (JIA) but difficult to examine
clinically due to its anatomical complexity. The aim of the study was to evaluate the role of ultrasonography (US)
of the ankle and midfoot (ankle region) in JIA. Doppler-US detected synovial hypertrophy, effusion and hyperemia
and US was used for guidance of steroid injection and to assess treatment efficacy.
Methods: Forty swollen ankles regions were studied in 30 patients (median age 6.5 years, range 1-16 years) with
JIA. All patients were assessed clinically, by US (synovial hypertrophy, effusion) and by color Doppler (synovial
hyperemia) before and 4 weeks after US-guided steroid injection.
Results: US detected 121 compartments with active disease (joints, tendon sheaths and 1 ganglion cyst). Multiple
compartments were involved in 80% of the ankle regions. The talo-crural joint, posterior subtalar joint, midfoot
joints and tendon sheaths were affected in 78%, 65%, 30% and 55% respectively. Fifty active tendon sheaths were
detected, and multiple tendons were involved in 12 of the ankles. US-guidance allowed accurate placement of the
corticosteroid in all 85 injected compartments, with a low rate of subcutaneous atrophy (4,7%). Normalization or
regression of synovial hypertrophy was obtained in 89%, and normalization of synovial hyperemia in 89%. Clinical
resolution of active arthritis was noted in 72% of the ankles.
Conclusions: US enabled exact anatomical location of synovial inflammation in the ankle region of JIA patients.
The talo-crural joint was not always involved. Disease was frequently found in compartments difficult to evaluate
clinically. US enabled exact guidance of steroid injections, gave a low rate of subcutaneous atrophy and was
proved valuable for follow-up examinations. Normalization or regression of synovial hypertrophy and hyperemia
was achieved in most cases, which supports the notion that US is an important tool in the management of ankle
involvement in JIA.
Background
The ankle region (ankle and midfoot) is frequently dis-
eased in juvenile idiopathic arthritis (JIA) [1,2] but the
anatomical complexity of this area makes it difficult to
evaluate clinically which of the numerous joints and sur-
rounding tendons are involved in the inflammatory pro-
cess. Several publications in adult rheumatology have
shown high sensitivity of ultrasonography (US) for early
detection of synovitis in various joints including the
ankle [3-11], but there are only few reports dealing with
pediatric rheumatology [12-14].
Intra-articular steroid injection is a treatment option
for JIA patients with mono- and oligoarticular involve-
ment or whose joints remain active during systemic
treatment [15]. The clinical response to a palpation-
guided intra-articular steroid injection is however poorer
in the ankle than in other joints [16,17], which may be * Correspondence: louise.laurell@skane.se
1Department of Pediatrics, Skåne University Hospital, Lund University,
Sweden
Full list of author information is available at the end of the article
Laurell et al. Pediatric Rheumatology 2011, 9:4
http://www.ped-rheum.com/content/9/1/4
© 2011 Laurell et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.due to the anatomical complexity of this region prevent-
ing accurate placement of the needle tip.
In the present study, we investigated the usefulness of
US of the ankle region in children with JIA for detection
of synovial hypertrophy and hyperemia, for guidance of
steroid injection and for assessment of treatment
efficacy.
Methods
The study was conducted over a period of 2.5 years
at the Department of Pediatrics (Rigshospital) of the
University of Copenhagen, Denmark. Forty ankle regions
were investigated in 30 JIA patients with active disease,
as judged by the treating physician. Twenty-one patients
were female (70%), 9 male (30%) and the median age of
the patients was 6.5 years (range 1-16). Eleven of the
children had poly-JIA (median age 10 years), and 19
oligo-JIA (median age 5 years). Demographic features,
clinical and laboratory assessment are listed in Table 1.
The study was approved by the local research ethics
committee (Videnskabsetiske Komiteer for Region
Hovedstaden), and all parents gave informed consent for
the participation of their children.
During the study period, an initial Doppler-US exami-
nation was performed (week 0) in all consecutive JIA
patients with a clinically diseased ankle region. US
revealed signs of synovitis in a total of 36 patients, 10
with involvement of both ankle regions. Six patients
were excluded due to non-participation at follow-up,
leaving 30 patients and 40 ankle regions for evaluation.
At inclusion 26 patients had ongoing systemic treat-
ment, 15 with methotrexate, 6 with methotrexate and
biologics (3 etanercept, 2 adalimumab and 1 abatacept),
and 5 with systemic corticosteroids. Four patients
received an intra-articular steroid injection within the
previous 3 months, but not in the same extremity. The
pediatric rheumatologist and the radiologist made con-
sensus decisions based on both clinical complaints and
imaging results regarding which compartments to inject.
Clinical and US assessment
Patients diagnosed with JIA, based on the revised cri-
teria of the International League of Associations for
Rheumatology (ILAR, 2004) [18], were examined by one
of two experienced pediatric rheumatologists for clinical
signs of involvement of the ankle region. Recorded clini-
cal variables were: swelling, pain assessed by the patient/
parent (Visual Analogue Scale, VAS), tenderness at pal-
pation and limitation in the range of motion.
Patients with clinically active arthritis (swelling or lim-
ited range of motion with pain or tenderness) were
assessed with US on the same day. The US examiner was
a radiologist specialized in musculoskeletal US using a
GE Logiq 9 scanner (General Electric Corporation, USA)
equipped with a 16-4 MHz linear transducer (4D16L).
The following joints and tendon sheaths were examined:
anterior, anteromedial and anterolateral talo-crural joint
(anterior, anteromedial and anterolateral recesses), pos-
terior subtalar joint (lateral recess), anterior subtalar joint
(dorsal and medial recesses), tibialis posterior, flexor digi-
torum longus, flexor hallucis longus, peroneus, tibialis
anterior, extensor hallucis longus, and extensor digi-
torum longus. For each of these compartments the fol-
lowing US signs of disease were registered: synovial
hypertrophy (presence/absence) and joint effusion (pre-
sence/absence) according to the OMERACT 7 (Outcome
Measures in Rheumatology) definitions for ultrasono-
graphic pathology in inflammatory arthritis [19].
Table 1 Clinical and laboratory assessment in 30 JIA
patients with 40 symptomatic ankles*
Characteristic Number
(%)
Median Range
Sex
Male 9 (30%)
Female 21 (70%)
Subgroups
RF-negative polyarthritis 11 (37%)
Oligoarthritis extended 6 (20%)
Oligoarthritis persistent 13 (43%)
Other subgroups 0
Age at injection, years 6.5 1-16
Disease duration, years 2.0 0.5-13.9
Number of joints (n = 40) with
Swelling 38 (95%)
Pain 35 (88%)
Tenderness at palpation 39 (98%)
Limited range of motion 34 (85%)
Active arthritis 40 (100%)
VAS ankle pain patient/parent, cm 3.5 0.2-10.0
VAS global assessment
patient/parent, cm
0.6 0-9.7
VAS global assessment physician, cm 2.8 1-6.8
CRP level, mg/l 2 0-22
ESR, mm/hour 14 8-69
HLA B27 positive, number of
patients
5 (17%)
ANA positive, number of patients 14 (47%)
Second-line drug therapy
Methotrexate 15 (50%)
Biologic therapies
Etanercept 3 (10%)
Adalimumab 2 (7%)
Abatacept 1 (3%)
Systemic corticosteroid therapy 5 (17%)
* RF = rheumatoid factor; VAS = visual analog scale; CRP = C-reactive protein;
ESR = erythrocyte sedimentation rate; HLA = human leukocyte antigen; ANA =
antinuclear antibodies.
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quantitative grading of color Doppler flow, where 0 indi-
cates absence of flow and 1-3 indicates hyperemia. In the
talo-crural joint, the synovial thickness of the anterior
recess was also measured at 4 locations (proximal and
distal on the midline, anterior to medial malleolus, and
anterior to lateral malleolus). A mean synovial thickness
(MST) was calculated from the 4 measurements at each
occasion. The MST values before and after steroid injec-
tion were compared with paired t-test. Bone or cartilage
erosions were registered if present.
US-guided steroid injection
For all US-guided injections triamcinolone acetonide
40 mg/ml was used according to local established prac-
tice. Dose estimation was based on the size of compart-
ment to inject and the age of the child. Injections were
performed by a free-hand technique using a 12-5 MHz
linear hockey-stick transducer (i12L). The needle (21 G
for joints, 23 G for tendon sheaths) was inserted along
the US plane into joint recesses or tendons sheaths. The
talo-crural joint was punctured anteromedially (Figure
1) or anterolaterally, the posterior subtalar joint antero-
laterally (anterior to the peroneus tendons) - the antero-
lateral recess of the posterior subtalar joint was found
from a coronal plane at the level of the tarsal sinus
angling the transducer posteriorly (Figure 2). The talo-
calcaneo-navicular joint was punctured dorsally or
medially.
Follow-up after injection
All patients underwent the same clinical and US assess-
ment before (week 0) and at 4 weeks after the steroid
injection. For the talo-crural joint, a decrease in MST of
≥80% was regarded as ‘normalization’ (inactive synovial
tissue). A decrease of 20-80% was considered as ‘regres-
sion’. For the other joints and tendons, only the pre-
sence (no treatment effect) or absence (normalization
after treatment) of synovial hypertrophy was recorded.
In the follow-up of synovial hyperemia, normalization
was defined as total absence (grade 0) of color Doppler
flow.
Results
At week 0, Doppler US detected synovial hypertrophy,
effusion, and/or hyperemia in 121 compartments (joints,
tendon sheaths, and a ganglion cyst) (Table 2). Most
ankles (n = 32) had involvement of multiple compart-
ments. Synovial hypertrophy was found in 31 talo-crural
joints (Table 2), and in 9 of those (29%) it was localized,
involving only the lateral, anterior, or anterolateral
aspect of the joint (2, 3, and 4 joints, respectively). Iso-
lated talo-crural synovial hypertrophy was found in only
8% (3/40) of the ankles. The compartments most
frequently involved in association with the talo-crural
joint were the posterior subtalar joint (77%, 24/31) and
tendon sheaths (48%, 15/31). Synovial hypertrophy was
detected in 26 posterior subtalar joints (Table 2). Only 1
ankle showed isolated involvement of the posterior sub-
talar joint. In the 12 diseased midfoot areas, synovial
hypertrophy was found in 10 talo-navicular joints, 2
naviculo-cuneiform I joints, and 1 tarso-metatarsal V
joint (Table 2). Tendon involvement was found in 36
medial, 9 lateral and 5 anterior tendon sheaths. It was
multiple in 12 ankles and bilateral in 2. Isolated tenosy-
novitis, without any joint involvement, was found in
only 4 patients.
Effusion was detected in 40% of the involved compart-
ments, mostly tendon sheaths (33/50, 66%), but also 9
talo-crural joints (29%), 5 ante r i o rs u b t a l a rj o i n t s( 4 2 % )
and 1 para-articular cyst. Color Doppler examination
showed synovial hyperemia in 108 of the 121 diseased
compartments (89%, Table 2). Bone erosions were found
in 3 patients, all in the talus. These subjects were 13-15
years old, 2 had polyarticular and 1 oligoarticular arthri-
tis, with disease duration of 6, 102, and 129 months,
respectively.
US-guided steroid injection was performed in 85 of
the 121 diseased compartments, and this was done
under general anesthesia in 26 patients (median age
5 years) and with nitrous oxide-oxygen analgesia in
4 patients (median age 15.5 years), according to local
practice. Triamcinolone acetonide 40 mg/ml was used
for all steroid injections. In joints, the injected dose was
40 mg in 83% (52/63) and 20 mg in the remaining 17%.
In tendon sheaths (1 or 2 per patient), the dose was
20 mg in 86% (18/21) and 40 mg in the rest. A dose of
20 mg was injected into the cyst.
In 14 of the patients other joints (mostly the knee, but
in some also the wrist or elbow) were injected with
triamcinolone hexacetonide in the same session. The
total steroid dose injected per patient was 40-340 mg
(mean 100 mg, median 80 mg). During the study period,
12 ankles had 1 injection, and 28 had multiple injections
(2-3 compartments in 25 ankles and 4-5 compartments
in 3 ankles). The total time demanded for US-guided
steroid injection including general anesthesia, was
approximately 30 minutes. The time for injection was
5-15 minutes, depending on the number and sites of
injections.
Ten patients had involvement of both ankle regions
during the study period. In 5 of these patients bilateral
symptoms occurred at the same time and both sides
were injected in the same session. In 3 patients, new
systemic therapies were started at the time of the steroid
injection: 2 were previously untreated and were given
methotrexate; the other patient had previously received
abatacept, which was switched to etanercept.
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Page 3 of 11Figure 1 US-guided steroid injection of the talo-crural joint . The needle is inserted obliquely into the antero-medial recess of the joint
(longitudinal US plane).
(a)                                (b)
(c)
Figure 2 US-guided injection in the antero-lateral recess of the posterior subtalar joint . (A-B) Lateral oblique longitudinal scanning plane
at the level of the posterior tarsal sinus. (C) The tip of the needle (arrow) is seen in the enlarged hypoechoic antero-lateral recess (Syn) which is
bulging into the hyperechoic fat of the tarsal sinus, between talus and calcaneus (Calc).
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US-guidance of the injection needle enabled real-time
visualization of the procedure and quick and effective
placement of the needle tip in all 85 of the treated com-
partments. Table 3 shows the effects on synovial hyper-
trophy detected in 85 injected and 36 non-injected
compartments 4 weeks after treatment, and Table 4 pre-
sents the effects on synovial hyperemia in 81 injected
and 27 non-injected compartments at the same time
point. Considering talo-crural joints synovial hypertro-
phy was normalized in 55% (17/31) and regressed in
32% (10/31), and there was an overall effect of steroid
injection in 87% (Table 3). Quantitative evaluation of
MST of the talo-crural joint before and 4 weeks after
steroid injection showed a statistically significant
decrease (p < 0.001, paired t-test). Normalization of
synovial hypertrophy was noted in 93% of the other
compartments (Table 3). Normalization of hyperemia
(grade 0) was seen in (72/81) 89% of injected compart-
ments, partial regression in 8 compartments (10%) and
persistent hyperemia (grade 2) in 1 compartment (1%)
(Table 4, Figure 3). There was an equally good result for
non-injected diseased compartments in most anatomical
sites, except the posterior subtalar joints where synovial
hypertrophy was normalized in only 60% and hyperemia
in 50%.
At clinical follow-up 4 weeks after steroid injection
29/40 ankles (72%) exhibited absence of active arthritis
and 11/40 had partially improved. The range of motion
was normalized in 29/40 ankles, partially improved in
9/40 and deteriorated in 2/40. Ankle pain totally
regressed in 29/40 ankles, partially improved in 8/40 and
deteriorated in 3/40. In 24/40 ankles (60%), all clinical
parameters were completely normalized after 4 weeks.
Relapses
Seven patients had relapse of symptoms and synovitis in
the ankle region, verified by Doppler-US, during the 2.5-
year study period. Two of these patients had a second
relapse, and 1 had 3 relapses. All 7 patients were re-
injected with US-guidance. In 4 of the 7 patients, local
steroid injection was the only treatment given. Three of
the patients were on second-line therapy (methotrexate)
at the time of relapse, and in 1 patient methotrexate
was added after the relapse. Relapse occurred in a pre-
viously injected compartment in 2 patients, in a different
compartment only in 4 patients, and in both a pre-
viously injected and a different compartment in 1
patient. Relapses occurred after a mean of 6.3 months
(median 6 months, range 4-11 months) and re-injections
were performed within 1-2 weeks of relapse.
Complications
Local subcutaneous atrophy was registered in 3 patients
(2 two-year-olds and 1 nine-year-old) at 4 injection sites
(1 talo-crural joint and 3 tendon sheaths), which repre-
sents a complication rate of 4.7% (4/85). No other com-
plications were noted.
Discussion
New disease-modifying therapy for JIA has changed the
outcome and increased the need for imaging techniques
more sensitive and specific than clinical examination
alone. In three recent studies clinical examination and
US findings of the ankle in children with JIA were com-
pared, and clinical assessment was found to be inade-
quate in identifying the structures involved [12,14,20].
Several other studies have also shown US to be superior
to clinical assessment for the detection of active
Table 2 US diagnosis of synovial hypertrophy and
hyperemia in 40 ankles at week 0
Compartment Number
of ankles
Number of compartments with
synovial hypertrophy (hyperemia)
Talo-crural
joint
31 (78%) 31 (29)
Post-subtalar
joint
26 (65%) 26 (25)
Midfoot joints 12 (30%) 13* (12)
Tendon
sheaths
22 (55%) 50** (41)
Para-articular
cyst
1 (3%) 1 (1)
All
compartments
121 (108)
* One ankle with involvement of 2 anterior subtalar joints.
** Twelve ankles with involvement of multiple tendons.
Table 3 Effect on synovial hypertrophy in 121 compartments 4 weeks after US-guided steroid injection
85 injected compartments 36 non-injected compartments
Normalization or regression No effect Normalization or regression No effect
Talo-crural joints (31) 27/31 (87%) 4/31 (13%) - -
Post-subtalar joints (26) 20/21 (95%) 1/21 (5%) 3/5 (60%) 2/5 (40%)
Midfoot joints (13) 10/11 (91%) 1/11 (9%) 2/2 (100%) 0
Tendons (50) 18/21 (86%) 3/21 (14%) 28/29 (97%) 1/29 (3%)
Para-articular cyst (1) 1/1 (100%) 0 - -
All compartments (121) 76/85 (89%) 9/85 (11%) 33/36 (92%) 3/36 (8%)
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Screening of JIA patients with US have revealed subcli-
nical synovitis in 35-51%, leading to reclassification of
patients as having polyarticular disease [12,20], which is
in agreement with a previous report on RA [29].
US is suitable for examination of children of all ages
and has certain advantages over MRI [30,31] being
cheaper, mobile, instantly accessible bedside, easy to
combine with clinical assessment (interactivity) and
non-invasive. It does not require sedation, which facili-
tates repetitive examinations. Assessment of multiple
locations is possible during the same session. Agitation
is rarely a problem and young children can be seated in
a parent’s lap or play while being examined. Modern
high-frequency US transducers provide unsurpassed
resolution of the superficial musculoskeletal structures
in children. An advantage of MRI is its ability to
demonstrate bone marrow edema [32] a predictor of
bone erosions in RA [33], and erosions in difficult-to-
assess regions. Doppler-US adds further information by
depicting articular and para-articular soft tissue hypere-
mia [10,12,34]. The Doppler signal can distinguish
between active and inactive synovitis in RA, correlating
to clinical and laboratory data [35], MRI [10] and histol-
ogy [36]. Doppler-US is included in the ultrasonographic
definitions of synovitis, tenosynovitis and enthesitis in
adult rheumatology [19]. Different gradation systems of
Doppler flow are employed, using quantitative [37] or
semi-quantitative [10] methods. The latter is more fre-
quently used in clinical practice [38] and the method
used in our study. Hardly any data exists on the evalua-
tion of synovial hyperemia by Doppler-US in JIA. Two
investigations have demonstrated a correlation between
Doppler flow and clinical activity [39,40].
Early involvement of the ankle region is common in
JIA. In a Swedish population-based study 52% of
patients with oligoarthritis and 22% with monoarthritis,
respectively, had ankle region involvement at the time
of diagnosis [2]. It is often assumed that ankle pain and
swelling represent talo-crural synovitis, with the occa-
sional exception of very obvious tendon involvement.
Our results show the complex distribution of synovial
involvement in multiple joints and tendon sheaths
(Table 2), in concordance with 2 recent US investiga-
tions [12,13] and 2 MRI studies [17,41] of JIA patients.
The present study is a descriptive interventional study
a n dw a sn o td e s i g n e dt oc o m p a r er e s u l t sf r o mc l i n i c a l
and US assessments. In our investigation the talo-crural
joint was involved in 78%, other studies report rates of
85% [17], 55% [41], 61% [13] and 67% [14] respectively.
In our study the posterior subtalar joint was involved in
65%, compared to 40-77% in earlier reports [12,17,41].
Table 4 Effect on hyperemia in 108 compartments 4 weeks after US-guided steroid injection
81 injected compartments 27 non-injected compartments
Normalization No normalization Normalization No normalization
Talo-crural joints (29) 25/29 (86%) 4/29 (14%) - -
Post-subtalar joints (25) 20/21 (95%) 1/21 (5%) 2/4 (50%) 2/4 (50%)
Midfoot joints (12) 8/10 (80%) 2/10 (20%) 2/2 (100%) 0
Tendons (41) 18/20 (90%) 2/20 (10%) 21/21 (100%) 0
Para-articular cyst (1) 1/1 (100%) 0 - -
All compartments (108) 72/81 (89%) 9/81 (11%) 25/27 (93%) 2/27 (7%)
(a)( b)( c)
Figure 3 Effect of US-guided steroid injection in the talo-crural joint as revealed by color Doppler . (A) Before steroid injection there is
synovial hyperemia anterior to the medial malleolus (MM). T = talus. (B) One week after steroid injection there is partial regression of hyperemia.
(C) Normalization with complete regression of hyperemia 4 weeks after steroid injection.
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our study, compared to reports of 71 and 77% [13,41].
Tenosynovitis was isolated in 10% in our study, com-
pared to 39% [13] and 5% [41]. Medial tendons were
most frequently involved in our patients, in agreement
with earlier findings [13]. All reports of frequent invol-
vement of multiple compartments strongly suggest that
i m a g i n g ,M R Io rm o r ee a s i l yU S[ 2 7 ] ,s h o u l db ep e r -
formed prior to ankle injections in children with JIA.
In US, synovial hypertrophy is detected as solid, non-
compressible, hypoechoic tissue in connection to joint
lines or surrounding tendons [19]. In children detection
is more challenging than in adults as the synovial tissue
often is difficult to distinguish from the hypoechoic car-
tilage of epiphyses. To avoid diagnostic errors, it is
therefore important to have good knowledge of the age-
dependent normal US appearance of each joint, and to
use a meticulous scanning technique that allows clear
interpretation of possible anisotropic artifacts.
The presence of juxta-articular flow at color Doppler
examination in the growing child may either represent
normal flow of the well-vascularised cartilage of the epi-
physis or synovial hyperemia indicating inflammation.
Flow in the cartilage is probably indicating normal carti-
laginous flow in contrast to flow inside the synovium
which probably indicates hyperemia.
In our study one third of the diseased talo-crural
joints showed localized synovial hypertrophy with ante-
rior, medial, or lateral localization. Other investigators
using contrast-enhanced MRI have also found heteroge-
neous distribution of synovitis within joints [42]. Our
US protocol did not include the posterior aspect of the
talo-crural joint, and hence we cannot rule out any loca-
lized posterior synovitis.
The clinical effect of steroid injection into a joint or
bursa depends on accurate placement of the needle tip
in the affected cavity. Imaging-guided injections were
found to give significantly better results than palpation-
guided injections in adult arthritis/osteoarthritis in large
and small joints [43-45], in patients with painful
shoulders [46,47] and in children with JIA in the ankle
region [17].
To our knowledge, our study is the first to report on
US-guided steroid injection in the ankle region in JIA.
Common clinical practice in JIA has been to perform a
non-guided injection in the talo-crural joint when ankle
swelling is present. Injection of the subtalar joint or ten-
don sheaths is less commonly performed, which might
explain the poor outcome of steroid injections for ankle
disease in JIA [12,16,17]. In our study, US showed no
involvement of the talo-crural joint in 22% of cases, and
involvement of other compartments in association with
the talo-crural joint in 70%. The posterior subtalar joint
was the second most frequently involved compartment
in our study (65%). This joint is very difficult to inject
without imaging-guidance in children [17,48,49].
Subcutaneous atrophy is a well-recognized adverse
effect of intra-articular steroid injection in children, most
likely to occur in small or complex joints such as the
wrist or ankle in children under 4 years of age [50] or
with a larger injection volume [49]. Using US-guidance
in our study, the needle tip was always correctly localized
before injection and possible extravasation of steroid into
the subcutaneous tissue was detected immediately. To
prevent reflux of liquid into the needle track the needle
tip was inserted deeply into the superficially located ten-
don sheaths, and the needle was flushed with lidocaine
before withdrawal. All injections were followed by thor-
ough local compression. Despite these precautions, sub-
cutaneous atrophy did occur in 3 patients. Two of those
were very young, indicating that the volume of injected
steroid might have mattered.
Follow-up of treatment efficacy of arthritis patients
may be based on clinical examination and/or imaging.
For the talo-crural and posterior subtalar joint clinical
examination after steroid injection showed good results
in 89% after 1-30 weeks (median 6 weeks, posterior sub-
talar joint only) [49], in 82% after 4 weeks [41], and in
67% after 6 months [17]. These studies are not directly
comparable due to differences in design, number of
patients, needle guidance technique (fluoroscopy, palpa-
tion) and follow-up time.
US follow-up after steroid injection [51] or other
treatments [52] have been reported in several studies in
adult rheumatology, but only in a few studies in children
[21,24-26]. All JIA studies have focused on the knee and
hip and none on the ankle. Systemic treatment with
NSAID, DMARD, or corticosteroid [21,26] and intra-
articular steroid injection [24,25] showed a decrease of
effusion and synovial hypertrophy. Reduction in effusion
occurred earlier than decrease in synovial hypertrophy
[24,26].
Our study is the first reporting on US, and Doppler-
US, for follow-up of steroid injections in the ankle
region in JIA patients. We noted that effusion disap-
peared completely in the absolute majority of the
injected compartments after 1 week. Table 3 illustrates
the effect of US-guided steroid injection on synovial
hypertrophy, with an overall normalization or regression
of 89% at week 4, lowest for the talo-crural joint (87%,
Figure 4), and the tendon sheaths (86%, Figure 5), and
highest for other joints (91-95%, Figure 6). The some-
what lower result for the talo-crural joint might be
explained by the different way we recorded synovial
thickness in this particular joint. The large anterior
recess of the talo-crural joint is easily accessible to US.
Thus we evaluated the synovial membrane of that com-
partment in greater detail by measuring the thickness at
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detection of small areas of residual synovial tissue which
is often seen in inactive synovitis [53,54]. We considered
a residual synovial thickening of ≤20% at follow-up after
steroid injection in the talo-crural joint to be normal.
US synovial measurement was more challenging in the
other smaller compartments i.e. the tarsal joints and
tendon sheaths, and hence only the qualitative presence
(lack of treatment effect) or absence (normalization) of
synovial tissue was recorded.
Our finding of synovial hyperemia in almost all dis-
eased compartments in the ankle region agrees with
recent findings in JIA patients of hyperemia in 93% of
symptomatic MCP-joints [39], but is higher than the
77% detected in symptomatic knees [40]. Doppler-US
has become an important technique for follow-up of
adult arthritis after steroid injections [55] or systemic
anti-TNF [56]. In JIA only 2 studies have been
published, prior to our present study, using Doppler-US
for follow-up of systemic corticosteroid [40] and NSAID
[34] treatment.
We also performed US follow-up of the 36 diseased
compartments that did not receive steroid injections,
which has not been considered in previous studies. In
these compartments a high degree of normalization or
regression of synovial hypertrophy and hyperemia was
noted (Tables 3 and 4). An explanation for this benefi-
cial effect may be systemic absorption of steroid or the
presence of anatomical communications between adja-
cent injected and non-injected compartments. Arthro-
graphic studies have shown communication between the
talo-crural and the posterior subtalar joint in 4-16% of
adults [57] but only in 0.5% of children [48]. Normally,
there is no communication between the talo-crural joint
and peroneal or tibial posterior sheaths, but the talo-
crural joint may communicate with the flexor hallucis
longus or the flexor digitorum longus sheath in 10-20%
(a)( b)( c)
Figure 4 Effect of US-guided steroid injection in the talo-crural joint . (A) T = talus. Synovial thickening (Syn) anterior to the medial
malleolus (MM), as shown by US before, (B) 1 week and (C) 4 weeks after steroid injection. There is regression of synovial hypertrophy without
complete normalization.
(a)( b)
Figure 5 Effect of US-guided steroid injection in the sheath of the tibialis anterior tendon . (A) TA = tibialis anterior tendon, EHL =
extensor hallucis longus tendon. Transversal scanning plane before steroid injection. Anechoic effusion, hyperechoic synovial hypertrophy and
synovial hyperemia in the tendon sheath. (B) One week after injection there is complete regression of effusion, hypertrophy and hyperemia.
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the tendons with persistent disease 4 weeks after steroid
injection were of the communicating type.
Our US examination protocol did not include all com-
partments potentially causing symptoms in the ankle
region e.g. the posterior talo-crural joint and plantar
midfoot. A revised and more appropriate scanning pro-
tocol for juvenile arthritis that includes these structures
as well will be used in the future.
Conclusions
Our results highlight the value of US in pediatric rheu-
matology. US provided exact information of the anato-
mical location of inflamed structures in the ankle
region. The talo-crural joint was not always involved
and disease was frequently found in other compartments
difficult to evaluate clinically (as the posterior subtalar
joint). US enabled exact guidance of steroid injections
with a low rate of subcutaneous atrophy, and was well
suited for follow-up examinations. Normalization or
regression of synovial hypertrophy and hyperemia was
achieved in most cases, suggesting that US assessment
prior to steroid injection, and US guidance of injections
in this region would potentially improve treatment
efficacy.
Acknowlegments And Funding
The authors thank the Foundation for Assistance of Disabled in Skåne, the
Gyllenstiernska Krapperup Foundation, the Samariten Foundation, the Petter
Silfverskiöld Foundation and the Eva and Oscar Ahrén Research Foundation
for their financial support. We are grateful to Wyeth Denmark for providing
the US equipment.
Author details
1Department of Pediatrics, Skåne University Hospital, Lund University,
Sweden.
2Department of Diagnostic Imaging, Gildhøj Private Hospital,
University of Copenhagen, Denmark.
3Department of Pediatrics, Rigshospital,
University of Copenhagen, Denmark.
4Parker Institute, Frederiksberg Hospital,
University of Copenhagen, Denmark.
5Department of Pediatrics, University of
Gothenburg, Sweden.
Authors’ contributions
LL participated in the design of the study, in the ultrasound and clinical
examinations, in the acquisition of data, in the statistical analysis and was
responsible for the analysis of results and for the draft of the manuscript.
MCP participated in the design of the study and in the analysis of results,
performed the ultrasound examinations and helped to draft the manuscript.
SN participated in the design of the study, in performing the clinical
examinations and in revising the manuscript.
(a)( b)
(c) (d)
Figure 6 Effect of US-guided steroid injection in the antero-lateral recess of the posterior subtalar joint . Lateral oblique longitudinal
scanning planes. (A) Before injection there is an enlarged hypoechoic antero-lateral recess (Syn), with distinct deep margins (arrows), bulging
into the hyperechoic fat of the tarsal sinus between talus and calcaneus (Calc), and (B) synovial hyperemia at color Doppler examination. (C) One
week after injection the recess is not visualized (D) and there is complete regression of synovial hyperemia.
Laurell et al. Pediatric Rheumatology 2011, 9:4
http://www.ped-rheum.com/content/9/1/4
Page 9 of 11MZ participated in the design of the study, in performing the clinical
examinations and in revising the manuscript.
MB participated in the design of the study and in revising the manuscript.
AF participated in the design of the study, the analysis of results and in
drafting the manuscript.
All authors read and approved the final manuscript.
Authors’ Information
Louise Laurell M.D. is a Consultant in Pediatrics at the Department of
Pediatrics, Skåne University Hospital, Lund University, Sweden.
Michel Court-Payen M.D., Ph.D. is a Consultant in Radiology at the
Department of Diagnostic Imaging, Gildhøj Private Hospital, University of
Copenhagen, Denmark.
Susan Nielsen M.D. is a Consultant in Pediatrics, Department of Pediatrics,
Rigshospital, University of Copenhagen, Denmark.
Marek Zak M.D. is a Consultant in Pediatrics at the Department of Pediatrics,
Rigshospital, University of Copenhagen, Denmark.
Mikael Boesen M.D., Ph.D., is a Consultant in Radiology, Parker Institute,
Frederiksberg Hospital, University of Copenhagen, Denmark.
Anders Fasth M.D., Ph.D. is a Consultant and Professor of Pediatric
Immunology at the Department of Pediatrics, University of Gothenburg,
Sweden.
Competing interests
The authors declare that they have no competing interests.
Received: 5 November 2010 Accepted: 29 January 2011
Published: 29 January 2011
References
1. Flato B, Lien G, Smerdel A, Vinje O, Dale K, Johnston V, Sorskaar D, Moum T,
Ploski R, Forre O: Prognostic factors in juvenile rheumatoid arthritis: a
case-control study revealing early predictors and outcome after 14.9
years. J Rheumatol 2003, 30:386-393.
2. Gare BA, Fasth A: The natural history of juvenile chronic arthritis: a
population based cohort study. I. Onset and disease process. J
Rheumatol 1995, 22:295-307.
3. Weiner SM, Jurenz S, Uhl M, Lange-Nolde A, Warnatz K, Peter HH,
Walker UA: Ultrasonography in the assessment of peripheral joint
involvement in psoriatic arthritis: a comparison with radiography, MRI
and scintigraphy. Clin Rheumatol 2008, 27:983-989.
4. Filippucci E, Iagnocco A, Meenagh G, Riente L, Delle Sedie A, Bombardieri S,
Valesini G, Grassi W: Ultrasound imaging for the rheumatologist VII.
Ultrasound imaging in rheumatoid arthritis. Clin Exp Rheumatol 2007,
25:5-10.
5. Brown AK, O’Connor PJ, Roberts TE, Wakefield RJ, Karim Z, Emery P:
Recommendations for musculoskeletal ultrasonography by
rheumatologists: setting global standards for best practice by expert
consensus. Arthritis Rheum 2005, 53:83-92.
6. Scheel AK, Schmidt WA, Hermann KG, Bruyn GA, D’Agostino MA, Grassi W,
Iagnocco A, Koski JM, Machold KP, Naredo E, et al: Interobserver reliability
of rheumatologists performing musculoskeletal ultrasonography: results
from a EULAR “Train the trainers” course. Ann Rheum Dis 2005,
64:1043-1049.
7. Schmidt WA, Schmidt H, Schicke B, Gromnica-Ihle E: Standard reference
values for musculoskeletal ultrasonography. Ann Rheum Dis 2004,
63:988-994.
8. Szkudlarek M, Court-Payen M, Jacobsen S, Klarlund M, Thomsen HS,
Ostergaard M: Interobserver agreement in ultrasonography of the finger
and toe joints in rheumatoid arthritis. Arthritis Rheum 2003, 48:955-962.
9. Backhaus M, Burmester GR, Gerber T, Grassi W, Machold KP, Swen WA,
Wakefield RJ, Manger B: Guidelines for musculoskeletal ultrasound in
rheumatology. Ann Rheum Dis 2001, 60:641-649.
10. Szkudlarek M, Court-Payen M, Strandberg C, Klarlund M, Klausen T,
Ostergaard M: Power Doppler ultrasonography for assessment of
synovitis in the metacarpophalangeal joints of patients with rheumatoid
arthritis: a comparison with dynamic magnetic resonance imaging.
Arthritis Rheum 2001, 44:2018-2023.
11. Koski JM: Ultrasonography of the subtalar and midtarsal joints. J
Rheumatol 1993, 20:1753-1755.
12. Magni-Manzoni S, Epis O, Ravelli A, Klersy C, Veisconti C, Lanni S,
Muratore V, Scire CA, Rossi S, Montecucco C: Comparison of clinical versus
ultrasound-determined synovitis in juvenile idiopathic arthritis. Arthritis
Rheum 2009, 61:1497-1504.
13. Rooney ME, McAllister C, Burns JF: Ankle Disease in Juvenile Idiopathic
Arthritis: Ultrasound Findings in Clinically Swollen Ankles. J Rheumatol
2009, 37:1725-1729.
14. Pascoli L, Wright S, McAllister C, Rooney M: Prospective Evaluation of
Clinical and Ultrasound Findings in Ankle Disease in Juvenile Idiopathic
Arthritis: Importance of Ankle Ultrasound. J Rheumatol 2010,
37:2409-2414.
15. Ravelli A, Martini A: Juvenile idiopathic arthritis. Lancet 2007, 369:767-778.
16. Marti P, Molinari L, Bolt IB, Seger R, Saurenmann RK: Factors influencing
the efficacy of intra-articular steroid injections in patients with juvenile
idiopathic arthritis. Eur J Pediatr 2008, 167:425-430.
17. Remedios D, Martin K, Kaplan G, Mitchell R, Woo P, Rooney M: Juvenile
chronic arthritis: diagnosis and management of tibio-talar and sub-talar
disease. Br J Rheumatol 1997, 36:1214-1217.
18. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X,
Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, et al: International League
of Associations for Rheumatology classification of juvenile idiopathic
arthritis: second revision, Edmonton, 2001. J Rheumatol 2004, 31:390-392.
19. Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M,
D’Agostino MA, Sanchez EN, Iagnocco A, Schmidt WA, Bruyn GA, et al:
Musculoskeletal ultrasound including definitions for ultrasonographic
pathology. J Rheumatol 2005, 32:2485-2487.
20. Haslam KE, McCann LJ, Wyatt S, Wakefield RJ: The detection of subclinical
synovitis by ultrasound in oligoarticular juvenile idiopathic arthritis: a
pilot study. Rheumatology (Oxford) 2010, 49:123-127.
21. Kakati P, Sodhi KS, Sandhu MS, Singh S, Katariya S, Khandelwal N: Clinical
and ultrasound assessment of the knee in children with juvenile
rheumatoid arthritis. Indian J Pediatr 2007, 74:831-836.
22. El-Miedany YM, Housny IH, Mansour HM, Mourad HG, Mehanna AM,
Megeed MA: Ultrasound versus MRI in the evaluation of juvenile
idiopathic arthritis of the knee. Joint Bone Spine 2001, 68:222-230.
23. Gylys-Morin VM, Graham TB, Blebea JS, Dardzinski BJ, Laor T, Johnson ND,
Oestreich AE, Passo MH: Knee in early juvenile rheumatoid arthritis: MR
imaging findings. Radiology 2001, 220:696-706.
24. Cellerini M, Salti S, Trapani S, D’Elia G, Falcini F, Villari N: Correlation
between clinical and ultrasound assessment of the knee in children with
mono-articular or pauci-articular juvenile rheumatoid arthritis. Pediatr
Radiol 1999, 29:117-123.
25. Eich GF, Halle F, Hodler J, Seger R, Willi UV: Juvenile chronic arthritis:
imaging of the knees and hips before and after intraarticular steroid
injection. Pediatr Radiol 1994, 24:558-563.
26. Sureda D, Quiroga S, Arnal C, Boronat M, Andreu J, Casas L: Juvenile
rheumatoid arthritis of the knee: evaluation with US. Radiology 1994,
190:403-406.
27. d’Agostino MA, Ayral X, Baron G, Ravaud P, Breban M, Dougados M: Impact
of ultrasound imaging on local corticosteroid injections of symptomatic
ankle, hind-, and mid-foot in chronic inflammatory diseases. Arthritis
Rheum 2005, 53:284-292.
28. Szkudlarek M, Narvestad E, Klarlund M, Court-Payen M, Thomsen HS,
Ostergaard M: Ultrasonography of the metatarsophalangeal joints in
rheumatoid arthritis: comparison with magnetic resonance imaging,
conventional radiography, and clinical examination. Arthritis Rheum 2004,
50:2103-2112.
29. Wakefield RJ, Green MJ, Marzo-Ortega H, Conaghan PG, Gibbon WW,
McGonagle D, Proudman S, Emery P: Should oligoarthritis be reclassified?
Ultrasound reveals a high prevalence of subclinical disease. Ann Rheum
Dis 2004, 63:382-385.
30. Damasio MB, Malattia C, Martini A, Toma P: Synovial and inflammatory
diseases in childhood: role of new imaging modalities in the assessment
of patients with juvenile idiopathic arthritis. Pediatr Radiol 2010,
40:985-998.
31. McKay GM, Cox LA, Long BW: Imaging juvenile idiopathic arthritis:
assessing the modalities. Radiol Technol 2010, 81:318-327.
32. Jimenez-Boj E, Nobauer-Huhmann I, Hanslik-Schnabel B, Dorotka R,
Wanivenhaus AH, Kainberger F, Trattnig S, Axmann R, Tsuji W, Hermann S,
et al: Bone erosions and bone marrow edema as defined by magnetic
Laurell et al. Pediatric Rheumatology 2011, 9:4
http://www.ped-rheum.com/content/9/1/4
Page 10 of 11resonance imaging reflect true bone marrow inflammation in
rheumatoid arthritis. Arthritis Rheum 2007, 56:1118-1124.
33. McQueen FM, Benton N, Perry D, Crabbe J, Robinson E, Yeoman S,
McLean L, Stewart N: Bone edema scored on magnetic resonance
imaging scans of the dominant carpus at presentation predicts
radiographic joint damage of the hands and feet six years later in
patients with rheumatoid arthritis. Arthritis Rheum 2003, 48:1814-1827.
34. Shanmugavel C, Sodhi KS, Sandhu MS, Sidhu R, Singh S, Katariya S,
Khandelwal N: Role of Power Doppler sonography in evaluation of
therapeutic response of the knee in juvenile rheumatoid arthritis.
Rheumatol Int 2008, 28:573-578.
35. Naredo E, Bonilla G, Gamero F, Uson J, Carmona L, Laffon A: Assessment of
inflammatory activity in rheumatoid arthritis: a comparative study of
clinical evaluation with grey scale and power Doppler ultrasonography.
Ann Rheum Dis 2005, 64:375-381.
36. Walther M, Harms H, Krenn V, Radke S, Faehndrich TP, Gohlke F: Correlation
of power Doppler sonography with vascularity of the synovial tissue of
the knee joint in patients with osteoarthritis and rheumatoid arthritis.
Arthritis Rheum 2001, 44:331-338.
37. Hau M, Schultz H, Tony HP, Keberle M, Jahns R, Haerten R, Jenett M:
Evaluation of pannus and vascularization of the metacarpophalangeal
and proximal interphalangeal joints in rheumatoid arthritis by high-
resolution ultrasound (multidimensional linear array). Arthritis Rheum
1999, 42:2303-2308.
38. Schmidt WA: Technology Insight: the role of color and power Doppler
ultrasonography in rheumatology. Nature Clinical Practice Rheumatology
2007, 3:35-42.
39. Karmazyn B, Bowyer SL, Schmidt KM, Ballinger SH, Buckwalter K, Beam TT,
Ying J: US findings of metacarpophalangeal joints in children with
idiopathic juvenile arthritis. Pediatr Radiol 2007, 37:475-482.
40. Shahin AA, el-Mofty SA, el-Sheikh EA, Hafez HA, Ragab OM: Power Doppler
sonography in the evaluation and follow-up of knee involvement in
patients with juvenile idiopathic arthritis. Z Rheumatol 2001, 60:148-155.
41. Tynjala P, Honkanen V, Lahdenne P: Intra-articular steroids in
radiologically confirmed tarsal and hip synovitis of juvenile idiopathic
arthritis. Clin Exp Rheumatol 2004, 22:643-648.
42. Ostergaard M, Stoltenberg M, Henriksen O, Lorenzen I: Quantitative
assessment of synovial inflammation by dynamic gadolinium-enhanced
magnetic resonance imaging. A study of the effect of intra-articular
methylprednisolone on the rate of early synovial enhancement. Br J
Rheumatol 1996, 35:50-59.
43. Sibbitt WL Jr, Peisajovich A, Michael AA, Park KS, Sibbitt RR, Band PA,
Bankhurst AD: Does sonographic needle guidance affect the clinical
outcome of intraarticular injections? J Rheumatol 2009, 36:1892-1902.
44. Jones A, Regan M, Ledingham J, Pattrick M, Manhire A, Doherty M:
Importance of placement of intra-articular steroid injections. Bmj 1993,
307:1329-1330.
45. Peetrons P, Court-Payen M: Ultrasound-Guided Musculoskeletal
Interventional Procedures. In Imaging in Percutaneous Musculoskeletal
Interventions. Edited by: Gangi A, Guth S, Guermazi A. Springer;
2008:385-398.
46. Naredo E, Cabero F, Beneyto P, Cruz A, Mondejar B, Uson J, Palop MJ,
Crespo M: A randomized comparative study of short term response to
blind injection versus sonographic-guided injection of local
corticosteroids in patients with painful shoulder. J Rheumatol 2004,
31:308-314.
47. Eustace JA, Brophy DP, Gibney RP, Bresnihan B, FitzGerald O: Comparison
of the accuracy of steroid placement with clinical outcome in patients
with shoulder symptoms. Ann Rheum Dis 1997, 56:59-63.
48. Sahlstedt : Simultaneous arthrography of the talocrural and talonavicular
joints in children. I. Technique. Acta Radiol Diagn (Stockh) 1976,
17:545-556.
49. Beukelman T, Arabshahi B, Cahill AM, Kaye RD, Cron RQ: Benefit of
intraarticular corticosteroid injection under fluoroscopic guidance for
subtalar arthritis in juvenile idiopathic arthritis. J Rheumatol 2006,
33:2330-2336.
50. Job-Deslandre C, Menkes CJ: Complications of intra-articular injections of
triamcinolone hexacetonide in chronic arthritis in children. Clin Exp
Rheumatol 1990, 8:413-416.
51. Terslev L, Torp-Pedersen S, Qvistgaard E, Danneskiold-Samsoe B, Bliddal H:
Estimation of inflammation by Doppler ultrasound: quantitative changes
after intra-articular treatment in rheumatoid arthritis. Ann Rheum Dis
2003, 62:1049-1053.
52. Ziswiler HR, Aeberli D, Villiger PM, Moller B: High-resolution ultrasound
confirms reduced synovial hyperplasia following rituximab treatment in
rheumatoid arthritis. Rheumatology (Oxford) 2009, 48:939-943.
53. Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E,
Wakefield RJ, O’Connor PJ, Emery P: Presence of significant synovitis in
rheumatoid arthritis patients with disease-modifying antirheumatic
drug-induced clinical remission: evidence from an imaging study may
explain structural progression. Arthritis Rheum 2006, 54:3761-3773.
54. Frosch M, Foell D, Ganser G, Roth J: Arthrosonography of hip and knee
joints in the follow up of juvenile rheumatoid arthritis. Ann Rheum Dis
2003, 62:242-244.
55. Filippucci E, Farina A, Carotti M, Salaffi F, Grassi W: Grey scale and power
Doppler sonographic changes induced by intra-articular steroid injection
treatment. Ann Rheum Dis 2004, 63:740-743.
56. Naredo E, Moller I, Cruz A, Carmona L, Garrido J: Power Doppler
ultrasonographic monitoring of response to anti-tumor necrosis factor
therapy in patients with rheumatoid arthritis. Arthritis Rheum 2008,
58:2248-2256.
57. Trnka HJ, Ivanic G, Trattnig S: Arthrography of the foot and ankle. Ankle
and subtalar joint. Foot Ankle Clin 2000, 5:49-62, vi.
58. Cassar-Pullicino VN, Tins B: Anatomy, arthrography, Bursography and
Tenography of the Ankle and Foot. In imaging of the Foot and Ankle
Edited by: Verlag S 2003, 27-42.
doi:10.1186/1546-0096-9-4
Cite this article as: Laurell et al.: Ultrasonography and color Doppler in
juvenile idiopathic arthritis: diagnosis and follow-up of ultrasound-
guided steroid injection in the ankle region. A descriptive
interventional study. Pediatric Rheumatology 2011 9:4.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Laurell et al. Pediatric Rheumatology 2011, 9:4
http://www.ped-rheum.com/content/9/1/4
Page 11 of 11